Digital Edition

Abstracts Presented at the 2018 AVAHO Annual Meeting

September 28-30, 2018 ► Chicago, IL

Fed Pract. 2018 August;35(suppl)

Recommended Reading

Do Erythropoiesis-Stimulating Agents Have a Risk Evaluation and Mitigation Strategy? (FULL)

Open Clinical Trials for Patients With Renal Cell Carcinoma (FULL)

Hematology and Oncology Federal Health Data Trends (FULL)

Former Smokers Motivate Quitters

Colorectal cancer: New observations, new implications

VA and NCI Join to Provide Leading-Edge Cancer Treatment

FDA warns against azithromycin in blood or lymph node cancers

New chronic lymphocytic leukemia guidelines from the UK

Advances in Hematology and Oncology (August 2018)

Could An Antibiotic Be the Next Great Oncologic Drug?

Clinical Topics

Digital Edition

AVAHO 2021 Meeting Posters and Abstracts
Publish date: September 22, 2021
Advances in Hematology and Oncology
Publish date: September 3, 2021
Advances in Hematology and Oncology
Publish date: May 20, 2021
August 2020 Advances in Precision Oncology
Abstracts Presented at the 2020 AVAHO Annual Meeting (Digital Edition)

Multimedia

Experts break down latest CAR T-cell advances in lymphoma
Publish date: January 22, 2020
SC daratumumab deemed feasible for every multiple myeloma patient
Publish date: July 11, 2019
Researchers propose new risk groups for NK-AML
Publish date: May 8, 2019

Conference Coverage

I am not fine: The heavy toll cancer takes
Publish date: October 5, 2022
Blood test for multiple cancers: Many false positives
Publish date: September 12, 2022
Patients with blood cancers underutilize palliative care
Publish date: June 23, 2022
Novel COVID-19 vaccine could fill the void for patients with blood cancers
Publish date: April 18, 2022
NHL: As a second-line treatment in phase 3 trial, tisa-cel disappoints
Publish date: December 15, 2021
TKI/BiTE combo extends survival of older patients with Ph+ALL
Publish date: December 15, 2021
Myeloid patients respond robustly to Moderna COVID vaccine
Publish date: December 12, 2021
For leukemias, COVID-19 death risks tied to poor prognoses, ICU deferrals
Publish date: December 11, 2021
Bleeding disorder diagnoses delayed by years in girls and women
Publish date: March 9, 2021
CAR T-cell products shine in real-world setting, reveal new insights
Publish date: February 18, 2021

CLL incidence by race and location

Question 1 of 5